Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9786
-0.0314 (-3.11%)
At close: Jul 31, 2025, 4:00 PM
0.9899
+0.0113 (1.15%)
After-hours: Jul 31, 2025, 5:58 PM EDT
Lucid Diagnostics Employees
Lucid Diagnostics had 72 employees as of December 31, 2024. The number of employees increased by 2 or 2.86% compared to the previous year.
Employees
72
Change (1Y)
2
Growth (1Y)
2.86%
Revenue / Employee
$57,958
Profits / Employee
-$985,208
Market Cap
105.67M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 72 | 2 | 2.86% |
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LUCD News
- 10 hours ago - PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 - PRNewsWire
- 1 day ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - PRNewsWire
- 1 day ago - PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 15 days ago - MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire
- 6 weeks ago - Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire
- 2 months ago - Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - PRNewsWire
- 2 months ago - PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript - Seeking Alpha